Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-10-26-Speech-3-233"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20051026.18.3-233"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"I could not agree more with the honourable Member about the unfolding tragedy of HIV infection cases amongst women and girls. As we know, the European and Developing Countries Clinical Trials Partnership is a group of 14 Member States plus Norway from outside the European Union.
The initial investment to establish the partnership was provided by the European Commission with a EUR 200 million allocation over five years through the Sixth Research and Development Framework Programme which runs from 2002 to 2006. The partnership has a total budget of EUR 600 million for the period from 2003 to 2007: in addition to the EUR 200 million provided by Community funding, EUR 200 million will come from Member States and a further EUR 200 million will be sought from industry, charities and private organisations.
It is the responsibility of each Member State to contribute in kind through their national research activities. Various projects funded by public money in each Member State count towards the total EUR 200 million contribution.
The Council has identified a need for joined-up action between the Commission and Member States in partnership with the Clinical Trials Partnership to support the research and development of new tools to fight HIV/AIDS, malaria and tuberculosis, a fact underlined in the conclusions of the General Affairs Council on 24 May this year. The partnership has identified a number of specific research topics and will issue calls for research proposals for these topics over a two- to three-year period.
Only one trial relating to HIV was funded last year, which will look into providing anti-retroviral drugs to children with HIV. Calls for research proposals issued last month include a specific call for research on microbicides. The title of this call for research is ‘Capacity building for the conduct of phase I, II and III trials of vaginal microbicides against sexual transmission of HIV’. Applications will come in over the next few months and funding decisions will be made next year."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples